← All diseases Infectious diseases

Drug-resistant tuberculosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (60)Meta-analysis (18)Treatment guideline (2)Phase 3 study (14)Systematic review (13)Randomized controlled trial (13)Clinical trial (160)Review article (220)Early Study (Phase 1 or 2) (10)Case report (62)Laboratory or animal study (27)Commentary or editorial (27)Retracted publication (1) Studies currently recruiting participants only (23)

Filter

Publications and studies (1457)

• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Case of Multi-Drug Resistant Tubercular Pyomyositis in an Immunosuppressed Patient Presenting as Bacterial Infection. (2023/08/09) ♡
• Screening and molecular dynamics simulation of compounds inhibiting MurB enzyme of drug-resistant Mycobacterium tuberculosis: An in-silico approach. (2023/08/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. [Risk factors and predictors of drug resistance in tuberculosis: A comprehensive analysis of cases in Chile (2014-2018)]. (2023/08/01) ♡
• Frequency of rifampicin-resistant mycobacterium tuberculosis by GeneXpert MTB/RIF assay and its correlates among 2605 probable tuberculosis patients in upper Egypt. (2023/07/01) ♡
• Correlating clinical breakpoint concentration of moxifloxacin with gyrA mutations using the GenoType MTBDRsl assay Version 2.0. (2023/07/01) ♡
• Weight variation increases the risk of death during the intensive phase of treatment among MDR-TB patients: A retrospective study. (2023/07/01) ♡
• Discharge Outcomes of Severely Sick Patients Hospitalized with Multidrug-Resistant Tuberculosis, Comorbidities, and Serious Adverse Events in Kyrgyz Republic, 2020-2022. (2023/06/25) ♡
• Better understanding extrapulmonary tuberculosis: A scoping review of public health impact in Pakistan, Afghanistan, India, and Bangladesh. (2023/06/22) ♡
• The Effect of Inoculum Size on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis. (2023/06/15) ♡
• Prospective study on outcome of MDR-TB using the shorter regimen during COVID-19 pandemic. (2023/06/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Highlights on the Development, Related Patents, and Prospects of Lenacapavir: The First-in-Class HIV-1 Capsid Inhibitor for the Treatment of Multi-Drug-Resistant HIV-1 Infection. (2023/05/28) ♡
• Prognostication of treatment non-compliance among patients with multidrug-resistant tuberculosis in the course of their follow-up: a logistic regression-based machine learning algorithm. (2023/05/09) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Shorter regimens improved treatment outcomes of multidrug-resistant tuberculosis patients in Tanzania in 2018 cohort. (2023/05/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Scourge of tuberculosis: A rare case of simultaneous chylothorax and chylous ascites. (2023/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. An Insight into Advances in Developing Nanotechnology Based Therapeutics, Drug Delivery, Diagnostics and Vaccines: Multidimensional Applications in Tuberculosis Disease Management. (2023/04/12) ♡
• Development of DNA Bio-chip for Detection of Mutations of rpoB, embB and inhA Genes in Drug-Resistant Mycobacterium Tuberculosis. (2023/04/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. TB patients: Is sputum disinfection important? (2023/04/01) ♡
• A retrospective analysis of 1019 cases of tuberculous cervical lymphadenitis in a rural setup in 20 years. (2023/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tuberculosis and malnutrition: The European perspective. (2023/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Unraveling the Secrets Behind the Multidrug-Resistant Tuberculosis Treatment Outcome in Chronic Renal Failure Patients Requiring Hemodialysis: A Systematic Review. (2023/03/28) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Medicinal Plants as Therapeutic Alternatives to Combat Mycobacterium tuberculosis: A Comprehensive Review. (2023/03/08) ♡
• In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor. (2023/03/03) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Identification of potential inhibitors of Mycobacterium tuberculosis shikimate kinase: molecular docking, in silico toxicity and in vitro experiments. (2023/03/01) ♡
• Biocompatible and biodegradable copper-protocatechuic metal-organic frameworks as rifampicin carrier. (2023/03/01) ♡
• Analysis of the Mechanism of Action of Kushen in the Treatment of Tuberculosis Based on Network Pharmacology. (2023/03/01) ♡
• Epidemiology of tuberculosis in the Pacific island countries and areas, 2000-2020. (2023/02/22) ♡
• Osteoarticular tuberculosis cases in the southwest of China: A 9-year retrospective study. (2023/02/07) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Economic evaluation of shortened, bedaquiline-containing treatment regimens for rifampicin-resistant tuberculosis (STREAM stage 2): a within-trial analysis of a randomised controlled trial. (2023/02/01) ♡
• More treatment options for rifampicin-resistant tuberculosis: the role of economic evaluation in informing uptake. (2023/02/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. The effect of undernutrition on sputum culture conversion and treatment outcomes among people with multidrug-resistant tuberculosis: a systematic review and meta-analysis. (2023/02/01) ♡
• Application of ddPCR in detection of the status and abundance of EGFR T790M mutation in the plasma samples of non-small cell lung cancer patients. (2023/01/26) ♡
• Engineering zinc oxide hybrid selenium nanoparticles for synergetic anti-tuberculosis treatment by combining Mycobacterium tuberculosis killings and host cell immunological inhibition. (2023/01/26) ♡
• Performance of Xpert MTB/RIF and sputum microscopy compared to sputum culture for diagnosis of tuberculosis in seven hospitals in Indonesia. (2023/01/20) ♡
• Social Support, Quality of Care, and Patient Adherence to Tuberculosis Treatment in Peru: The Mediating Role of Nurse Health Education. (2023/01/19) ♡
• Genomic insights of mcr-1 harboring Escherichia coli by geographical region and a One-Health perspective. (2023/01/16) ♡
• Optimized LC-MS/MS quantification of tuberculosis drug candidate macozinone (PBTZ169), its dearomatized Meisenheimer Complex and other metabolites, in human plasma and urine. (2023/01/15) ♡
• Nonhydrolyzable d‑phenylalanine-benzoxazole derivatives retain antitubercular activity. (2023/01/15) ♡
• Hybridization Approach Toward Novel Antituberculars: Design, Synthesis, and Biological Evaluation of Compounds Combining Pyrazinamide and 4-Aminosalicylic Acid. (2023/01/13) ♡
• Analysis of drug resistance among difficult-to-treat tuberculosis patients in Ghana identifies several pre-XDR TB cases. (2023/01/12) ♡
• High risk of unsuccessful treatment outcome in migrant population with tuberculosis: Data from three Italian hospitals. (2023/01/10) ♡
• Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis. (2023/01/09) ♡
• Whole-genome sequencing to characterize the genetic structure and transmission risk of Mycobacterium tuberculosis in Yichang city of China. (2023/01/09) ♡
• Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India. (2023/01/04) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Mab2780c, a TetV-like efflux pump, confers high-level spectinomycin resistance in mycobacterium abscessus. (2023/01/01) ♡
• Tuberculosis treatment outcomes and patient support groups, southern India. (2023/01/01) ♡
• Outcomes and adherence of shorter MDR TB regimen in patients with multidrug resistant tuberculosis. (2023/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Disseminated multidrug-resistant tuberculosis and SARS-CoV-2 co-infection in a child with IL-12Rβ1 deficiency. (2023/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Eliminate TB by 2025? A case report of MDR TB to reaffirm the need of follow UP! (2023/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Need to reinvigorate tuberculosis research in India - A review of studies registered under clinical trial registry of India. (2023/01/01) ♡
• Elucidating the mechanism of antimicrobial resistance in Mycobacterium tuberculosis using gene interaction networks. (2023/01/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.